|
"Molecular Signatures of Lethal and Indolent Prostate Cancer"
|
7R01CA116337-03
|
$532,731
|
RUBIN, MARK
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
"Statistical Methods for Genetic Epidemiology"
|
5R01CA094069-07
|
$560,698
|
WHITTEMORE, ALICE
|
STANFORD UNIVERSITY
|
|
"Strength training, Self-efficacy, and Function in Blacks with Prostate Cancer."
|
1R21CA127784-01A1
|
$165,375
|
HURLEY, BERNARD
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S1
|
$48,687
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S2
|
$85,299
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership
|
3U54CA163071-07S3
|
$47,040
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
3R01CA227473-01S1
|
$293,469
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
|
3R01CA206025-03S1
|
$52,355
|
GUISE, THERESA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
3U54CA156734-08S1
|
$64,152
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221697-01S1
|
$47,364
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221697-02S1
|
$142,991
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S1
|
$62,420
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-04S2
|
$48,381
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
11th AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
|
1R13CA236113-01
|
$74,000
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor
|
1R01CA131445-01A1
|
$221,524
|
NIE, DAOTAI
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma
|
5R01CA129356-02
|
$359,596
|
Schuster, David
|
EMORY UNIVERSITY
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
3P20CA202925-03S1
|
$104,165
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-04S1
|
$48,872
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
3P20CA221696-02S1
|
$122,850
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
3-D Transrectal Ultrasound with 2-D Arrays
|
1R01CA116379-01A1
|
$248,168
|
YEN, JESSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
3D Model of Human Ewing Sarcoma
|
3R01CA180279-05S1
|
$221,019
|
MIKOS, ANTONIOS
|
RICE UNIVERSITY
|
|
5-A-DAY CUSTOMIZED SURVEY STUDY - TASK ORDER NO. 2
|
N02PC513009-003
|
|
HURWITZ, PAUL
|
WESTAT:1109753
|
|
8th Great Lakes Nuclear Receptors Conference (GLNRC)
|
1R13CA236225-01
|
$5,000
|
DEHM, SCOTT
|
UNIVERSITY OF MINNESOTA
|
|
A biophysical approach to elucidating the molecular mechanisms of mitotic inhibitor targets
|
4K00CA223018-02
|
$80,244
|
MICKOLAJCZYK, KEITH
|
ROCKEFELLER UNIVERSITY
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
1R01CA129484-01A1
|
$393,213
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A genomic scan of hereditary prostate cancer families with an occurrence of colon
|
1R03CA133938-01
|
$88,000
|
STANFORD, JANET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A longitudinal assessment of frailty in young adult survivors of childhood cancer
|
3R01CA174851-05S1
|
$119,204
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
A Mixed Methods Study to Explore the Effect of Hurricanes Irma and Maria on Cancer Care in Puerto Rico
|
1R21CA239456-01
|
$181,398
|
COLON, VIVIAN
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
A model of smoking relapse: an assessment of stress, discrimination and socioeconomic status
|
3R01CA190329-04S1
|
$115,391
|
WETTER, DAVID
|
UNIVERSITY OF UTAH
|
|
A Mouse Model for Prostate Cancer
|
7U01CA084294-10
|
$1,446,104
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A multi-fluorescent intravital microscopy approach to study osteosarcoma
|
7R21CA208618-02
|
$176,380
|
INTINI, GIUSEPPE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-02
|
$426,676
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A New Class of Mechanistic Risk Prediction Models for Cancer Treatment Outcomes
|
1R21CA131603-01
|
$170,820
|
HUANG, LI-SHAN
|
UNIVERSITY OF ROCHESTER
|
|
A new method for multiplex detection of micro-RNAs (miR-ID)
|
1R43CA134277-01A1
|
$300,580
|
KAZAKOV, SERGEI
|
SOMAGENICS, INC.
|
|
A New Small-Molecule Kinase Inhibitor for Breast Cancer
|
1R41CA235943-01
|
$300,000
|
HOLTZMAN, MICHAEL
|
NUPEAK THERAPEUTICS, INC.
|
|
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
|
7R01CA207645-03
|
$575,548
|
OSBORNE, JOSEPH
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A New Tool for Discovery, Assay and Validation of Biomarkers in Prostate Cancer
|
1R43CA135903-01
|
$132,179
|
Stroobant, Paul
|
DIFFERENTIAL PROTEOMICS, INC.
|
|
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
|
3R44CA165314-04S1
|
$1,400
|
LU, XUANYONG
|
IMCARE BIOTECH
|
|
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy
|
5R01CA104035-04
|
$280,899
|
JING, NAIJIE
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
|
2R44CA214076-02
|
$999,997
|
KEOGH, MICHAEL-CHRISTOPHER
|
EPICYPHER, INC.
|
|
A Novel Synthetic Androgen Receptor Antagonist
|
1R01CA131137-01A1
|
$323,700
|
DONG, ZHONGYUN
|
UNIVERSITY OF CINCINNATI
|
|
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement
|
3U43CA221567-01S1
|
$49,951
|
PLACE, ROBERT
|
MIRECULE, INC.
|
|
A Pharmacogenetic approach to prostate cancer susceptibility
|
5R03CA128028-02
|
$74,000
|
Kidd, La Creis
|
UNIVERSITY OF LOUISVILLE
|
|
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
|
4R44CA217591-02
|
$1,125,311
|
KAHN, STUART
|
SYNTRIX BIOSYSTEMS, INC.
|
|
A phase II study of IPI-504 in metastatic hormone refractory prostate cancer
|
1R21CA128352-01A1
|
$268,452
|
oh, william
|
DANA-FARBER CANCER INSTITUTE
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
3R44CA221513-02S1
|
$4,319
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
A Quality Control Program for Quantitative MRI Data Acquisition and Analysis in Multi-site Clinical Trials
|
1R44CA235820-01
|
$224,422
|
KARAULANOV, TODOR
|
QALIBREMD, INC.
|
|
A real-time, cost-effective, accurate UV measurement and sun protection system to prevent and reduce the incidence of sunburn in high-risk consumers.
|
4R44CA224658-02
|
$686,491
|
MEITL, MATTHEW
|
WEARIFI, INC.
|
|
A Rigid Multivalent Chemical Platform for Targeted Diagnostics and Therapeutics
|
1F32CA132332-01A1
|
$51,278
|
Nasr, Khaled
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A role for c-Abl/Arg in melanoma progression
|
3R01CA166499-05S1
|
$51,515
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|